Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy

Next Previous
Trial Profile

A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 21 Dec 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pancrelipase (Primary)
  • Indications Exocrine pancreatic insufficiency
  • Focus Registrational; Therapeutic Use
  • Sponsors Abbott Healthcare Products

Most Recent Events

  • 26 Oct 2022 Results of post hoc analysis assessing the impact of pancrelipase delayed-release capsules on exocrine pancreatic insufficiency (EPI) symptoms as reported by patients through daily diaries presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2022.
  • 13 Mar 2018 New trial record
  • 16 Sep 2009 Results (n=52) assessing safety and efficacy published in the Trial Registry

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top